Weixinkang has been surveyed by 5 institutions: In the future, with the gradual increase in the coverage of 12V hospitals, it will bring continuous business growth to the company, which is the first curve of business growth (with survey questions and answers) Post date May 16, 2022 — 12:55 Post Lock Read More Weixinkang: At present, there is no production plan and alternative products of compound glycyrrhizin for injection. Post date May 13, 2022 — 11:44 Post Lock Read More Yongying Medical and Health's stock C net value rose 3.82%_Sina Finance_Sina.com Post date May 10, 2022 — 08:20 Post Lock Read More Yongying Medical and Health stock A net value rose 3.83% stock_Sina Finance_Sina.com Post date May 10, 2022 — 08:18 Post Lock Read More Each transaction volume of 105 shares increased by more than 50% _ Oriental Fortune Net Post date May 5, 2022 — 20:44 Post Lock Read More Afternoon Commentary: The three major A-share indexes fluctuated sideways, the Shanghai index rose 0.37%, and hepatitis concept stocks rose in the afternoon. Post date April 29, 2022 — 11:21 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022_Shenzhen Hotline Post date April 29, 2022 — 00:56 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022 – yqqlm Post date April 29, 2022 — 00:49 Post Lock Read More Weixin Kang: Net profit in 2021 will increase by 64% year-on-year, and it is expected that 3 products will be approved in 2022 Post date April 29, 2022 — 00:49 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
Weixinkang: At present, there is no production plan and alternative products of compound glycyrrhizin for injection. Post date May 13, 2022 — 11:44 Post Lock Read More Yongying Medical and Health's stock C net value rose 3.82%_Sina Finance_Sina.com Post date May 10, 2022 — 08:20 Post Lock Read More Yongying Medical and Health stock A net value rose 3.83% stock_Sina Finance_Sina.com Post date May 10, 2022 — 08:18 Post Lock Read More Each transaction volume of 105 shares increased by more than 50% _ Oriental Fortune Net Post date May 5, 2022 — 20:44 Post Lock Read More Afternoon Commentary: The three major A-share indexes fluctuated sideways, the Shanghai index rose 0.37%, and hepatitis concept stocks rose in the afternoon. Post date April 29, 2022 — 11:21 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022_Shenzhen Hotline Post date April 29, 2022 — 00:56 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022 – yqqlm Post date April 29, 2022 — 00:49 Post Lock Read More Weixin Kang: Net profit in 2021 will increase by 64% year-on-year, and it is expected that 3 products will be approved in 2022 Post date April 29, 2022 — 00:49 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
Yongying Medical and Health's stock C net value rose 3.82%_Sina Finance_Sina.com Post date May 10, 2022 — 08:20 Post Lock Read More Yongying Medical and Health stock A net value rose 3.83% stock_Sina Finance_Sina.com Post date May 10, 2022 — 08:18 Post Lock Read More Each transaction volume of 105 shares increased by more than 50% _ Oriental Fortune Net Post date May 5, 2022 — 20:44 Post Lock Read More Afternoon Commentary: The three major A-share indexes fluctuated sideways, the Shanghai index rose 0.37%, and hepatitis concept stocks rose in the afternoon. Post date April 29, 2022 — 11:21 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022_Shenzhen Hotline Post date April 29, 2022 — 00:56 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022 – yqqlm Post date April 29, 2022 — 00:49 Post Lock Read More Weixin Kang: Net profit in 2021 will increase by 64% year-on-year, and it is expected that 3 products will be approved in 2022 Post date April 29, 2022 — 00:49 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
Yongying Medical and Health stock A net value rose 3.83% stock_Sina Finance_Sina.com Post date May 10, 2022 — 08:18 Post Lock Read More Each transaction volume of 105 shares increased by more than 50% _ Oriental Fortune Net Post date May 5, 2022 — 20:44 Post Lock Read More Afternoon Commentary: The three major A-share indexes fluctuated sideways, the Shanghai index rose 0.37%, and hepatitis concept stocks rose in the afternoon. Post date April 29, 2022 — 11:21 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022_Shenzhen Hotline Post date April 29, 2022 — 00:56 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022 – yqqlm Post date April 29, 2022 — 00:49 Post Lock Read More Weixin Kang: Net profit in 2021 will increase by 64% year-on-year, and it is expected that 3 products will be approved in 2022 Post date April 29, 2022 — 00:49 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
Each transaction volume of 105 shares increased by more than 50% _ Oriental Fortune Net Post date May 5, 2022 — 20:44 Post Lock Read More Afternoon Commentary: The three major A-share indexes fluctuated sideways, the Shanghai index rose 0.37%, and hepatitis concept stocks rose in the afternoon. Post date April 29, 2022 — 11:21 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022_Shenzhen Hotline Post date April 29, 2022 — 00:56 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022 – yqqlm Post date April 29, 2022 — 00:49 Post Lock Read More Weixin Kang: Net profit in 2021 will increase by 64% year-on-year, and it is expected that 3 products will be approved in 2022 Post date April 29, 2022 — 00:49 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
Afternoon Commentary: The three major A-share indexes fluctuated sideways, the Shanghai index rose 0.37%, and hepatitis concept stocks rose in the afternoon. Post date April 29, 2022 — 11:21 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022_Shenzhen Hotline Post date April 29, 2022 — 00:56 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022 – yqqlm Post date April 29, 2022 — 00:49 Post Lock Read More Weixin Kang: Net profit in 2021 will increase by 64% year-on-year, and it is expected that 3 products will be approved in 2022 Post date April 29, 2022 — 00:49 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022_Shenzhen Hotline Post date April 29, 2022 — 00:56 Post Lock Read More Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022 – yqqlm Post date April 29, 2022 — 00:49 Post Lock Read More Weixin Kang: Net profit in 2021 will increase by 64% year-on-year, and it is expected that 3 products will be approved in 2022 Post date April 29, 2022 — 00:49 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
Weixinkang: Net profit in 2021 will increase by 64% year-on-year. It is expected that 3 products will be approved in 2022 – yqqlm Post date April 29, 2022 — 00:49 Post Lock Read More Weixin Kang: Net profit in 2021 will increase by 64% year-on-year, and it is expected that 3 products will be approved in 2022 Post date April 29, 2022 — 00:49 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
Weixin Kang: Net profit in 2021 will increase by 64% year-on-year, and it is expected that 3 products will be approved in 2022 Post date April 29, 2022 — 00:49 Post Lock Read More [Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
[Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of Yongying Medical and Health A Fund_Oriental Fortune Network Post date April 24, 2022 — 11:05 Post Lock Read More
Caishen.CoCaishen.Co